 

””"'$é%¥§22.ti§lu‘.ﬁiﬁii§ “Magdacted \ .
Illllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ,/ -

lllIlllllllllllllllllllllllllllllilllllllllllllllllHHlllHllll
mmmmmmuumnumumunmuulmmumnu

cunlcal Case Report

 

Form Revised I

  
  
    
 
 
 

 

 
 

M A’ 6' ' 3 (For Collection of Cancerous Tissucrm;
AWAW. [WW/“7, M4126 saw/3
_ . / 0 Wu
J’# . W, “.167; C /3. ? ' : gnome-3mg, Hisln
“M r/J/m. ”W- - - , = 4 _——_._.._

 

 

[Informed Consent!

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT {NFORMAT ION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

our institution. .-

.‘A

 

lﬂame of Physician or Study Coordiniitor . ﬂignature / Date

 

Klinical Information}

 

 

 

 

 

 

 

GENERAL INFORMATION
Date of Birth (mm/dd/yyyy) Height Marital Status Race i Temperature
. , ,1 , E] Single Warned _,
Gender Weight :1 Divorced r3 Widow Blood Pressure Heart Rate
‘fQ’Male Cl Female

 

 

 

 

 

 

HISTORY OF PRESENT ILLNESS

Chief Complaints: U06 ceQ cﬂtcméf/ ;, wceiyee 9>\W@CW{Mg ,
symptoms: WUA‘QM’" LOSS ) :fQUQ’l .

Clinical Findings:

 

 

 

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic 80-90 Symptomatic but Fully Ambulatory a 60-70 Symptomatic, in bed less than 50% of day
:1 40-50 S mptomatic. in bed more than 50% of day. but not bed ridden a 2030 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Dose Route

 

PAST MEDICAL HISTORY
u Status

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OB/GYN HISTORY
Menopausal Status Date of First Menses # of Pregnancies
D Pre-menopausal
r3 Peri—Menopausal Date of Last Menses # of Live Births
Ci Post-menopausal
Birth Control: [:3 Condom :3 Oral Contraceptive m IUD c1 Hormone Replacement
D Other: Therapy:
SOCIAL HISTORY
Occupation: [ Environmental Hazards:
Smoking History
Current Status TYPE Packs/day Duration When Quit
:3 YES gnNO ‘ (yrS) (yr)
Alcohol Consumption
Current Status TYPE Drinks] day Duration When Quit
:1 YES nPNO (yrs) (yr)
Dru Use
Current Status - TYPE Frequency Duration When Quit
:1 YES l?)N0 (yrs) (yr)

 

FAMILY MEDICAL HISTORY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA '
Test Result I Date i i Test Result Date
HIV ﬂ Negative El Positivezm CEA D Negative D Positive:
Hep B ﬂNegative E} Positive: .71 CA l5—3 t3 Negative U Positive:
Hep C ‘QNegative Cl Positive: 5 CA 19-9 D Negative D Positive:
AF P D Negative U Positive: PSA D Negative U Positive:
Other: . . . i
Cl Negative C] Posmvc: Other [3 Negative U Positive:
B/T Cell Markers:

 

 

 

 

DIAGNOSTIC STUDIES
Results
Ultrasound
x-
CT

Endosco
MRI
Bi

CLINICAL DIAGNOSIS
Clinical

Location of Involved L Nodes Location of Distant Metastasis

Date of
72 N Mg Stage: 3:.

 

 

[Treatment Information]

SURGICAL TREATMENT
Procedure Date of Procedure

Prima Tumor
Detailed Location

I
."6

Extension of Tumor

L Nodes
Location of L Nodes

Palpabie, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

Su
T N

NEOADJUVENT THERAPY or Molecular
reatment Dose Route Date
/ To
To
To
To
To

 

Pathology Form

 

[Specimen Informationl

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: ___ Date; Fime:_
Preserved by: _ Date; fime
SPECIMEN TYPE (# of samples provided)
Frozen Pa rafﬁn Block Blood/Serum/Piasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
4 o- a a rt 0
Time to LN2 Time to Formalin Time to LN2
/ 1/ min / 2. min min
PATHOLOGICAL DESCRIPTION
Primary Tumor
Organ . Size Extension of Tumor Distance to NAT
Z241? :7" 304:, z 2/ (2/ ”mark MW X / X cm ﬂ/vW/C cm
/ / Lymph Nodes
Location # Examined # Metastasized
Distant Metastasis
Organ Detailed Location Size

 

 

 

 

 

 

Pathological Staging

 

[9T2 N(

M 4-) Stage:

I

 

 

Notes:

[Mt/x10! ﬂ/A, ﬂag b '— W‘Zﬂe 53 )

 

 

 

[Microscopic Descriptionl

 

Histological Pattern

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cell Distribution + - Structural Pattern + -
Diffuse \5 StreaminL
Mosaic Storiform
Necrosis Fibrosis
Lymphocytic Inﬁltration )0 Palisading
Vascular Invasion Cystic Degeneration
Clusterized Bleeding
Alveolar Formation Myxoid Change
Indian File Psammoma/Calcification
Cellular Differentiation
Squamous + - Adenomatous + - Sarcomatous + Lymphomatous + -
Squamoid Cell Glandular cell ’7“ Round Cell Large Cell
Spindle Cell Cell Stratiﬁcation ' Fibroblast Small Cell
Kemtin Secretion Osteoblast RS Cell/RS Like
Desmosome Intracyt. Vacuole Lipoblast Inﬂam. Cell
Pearl Gland formation Myoblast Plasma Cell
Cellular Differentiation: El Well EModerate [3 Poor
Nuclear Appearance '
Nuclear Atypia: 0 I II III
Aniso Nucleosis \c
Hyperchromatism "x"
Nucleolar Prominent v
Multinucleated Giant Cell V
Mitotic Activity v
Nuclear Grade:
IHC Data
Marker Result Value Date
ER D Negative U Positive
PR D Negative [3 Positive
Her~2lneu Cl Negative [3 Positive
B-Cell Marker a Negative (3 Positive
T~Cell Marker a Negative a Positive
Other: [3 Negative C] Positive
Other: a Negative [:1 Positive

 

 

 

 

Histological Diagnosis:
/ Mild/ﬁr?” Jug/#8245511? "a???" ) “é

 

{Final Pathology Reporti

 

/'lr?/)///r'7é’c/(~qeo/7~ﬂi() /”<’ 7/5 //{¢//)¢H’C/

Z’QC I )
/

Grade:

 

 

Comments:

 

,z/l‘rincipal' investigator

Pathologist

 

